Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
Folliculogenesis01:20

Folliculogenesis

Folliculogenesis is the development of ovarian follicles, the specialized structures within the ovarian cortex where oogenesis, or egg development, occurs. This process is essential for female reproductive health and begins during fetal development when primordial follicles are formed. Each primordial follicle comprises a primary oocyte in the center, surrounded by a single layer of squamous pre-granulosa cells. These follicles remain dormant in late prophase I of meiosis until triggered by...
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Oogenesis01:22

Oogenesis

Oogenesis,  the process of developing egg cells (female gametes), occurs within the ovaries and is fundamental to female fertility. This sequence begins during fetal development when diploid oogonia in the developing ovaries undergo mitotic divisions to produce primary oocytes. By birth, these primary oocytes enter prophase I of meiosis but become arrested in this stage, remaining suspended until puberty.
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is known...
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A 25+ Year Journey on Yeast-Regulated Cell Death Research.

Current topics in microbiology and immunology·2026
Same author

Effect of Aromatherapy Massage With <i>Foeniculum vulgare</i> Mill. Seed Essential Oil Compared to Massage on Anxiety, Well-Being, and Sleep Quality: An Exploratory Randomized Study.

Health science reports·2026
Same author

A fragmented field: why ovarian biology needs dedicated integrative platforms.

Biology of reproduction·2026
Same author

Breaking free: Lung herniation following epicardial lead placement.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2026
Same author

Nitrogen utilization diversity in Torulaspora delbrueckii isolates relevant to food and beverage fermentations.

Food microbiology·2026
Same author

Spatial transcriptomics in the human adult ovary: insights into key signalling pathways during follicular atresia.

Human reproduction (Oxford, England)·2026
Same journal

A Programmed Drug-Loaded and Penetration-Delivery Functionalized Microneedle Patch for Synergistic Obesity Treatment.

Advanced healthcare materials·2026
Same journal

Antibacterial and Immunomodulatory Coatings for Orthopedic Metal Implants: Biological Rationale, Design Strategies, and Translational Challenges.

Advanced healthcare materials·2026
Same journal

Butyrylated PGAM5-Triggered and GSH-Responsive Cysteine Polymer Nanoparticles for CBL0137 Delivery to Enhance Necroptosis in Prostate Cancer.

Advanced healthcare materials·2026
Same journal

Dual-Modal Phototherapeutic Nanoagents Eradicating Drug-Resistant Bacteria via Multi-Pathway of Membrane Disruption, Oxidative Damage, and Energy Metabolism Interference.

Advanced healthcare materials·2026
Same journal

Smartphone-Enabled Point-of-Care Biosensing Platform With Self-Calibration for Rapid Matrix-Resistant Detection of Multiple AMI Biomarkers in Whole Blood.

Advanced healthcare materials·2026
Same journal

Multimetal-Doped Nanoenzymes Reprogram Macrophages for Immunotherapy of Gouty Arthritis.

Advanced healthcare materials·2026
See all related articles

Related Experiment Video

Updated: Jun 24, 2026

Collection of Human Follicular Fluid, Follicle Somatic Cells, and Immature Oocytes from Individuals Undergoing In Vitro Fertilization
06:40

Collection of Human Follicular Fluid, Follicle Somatic Cells, and Immature Oocytes from Individuals Undergoing In Vitro Fertilization

Published on: October 24, 2025

Bioengineering Ovarian Endocrine Function: From Follicle Modeling to Cell-Based Hormone Therapy.

Maria João Sousa1, Christiani A Amorim1

  • 1Pôle De Recherche en Physiopathologie de La Reproduction, Instituite of Experimental and Clinique Research, Université Catholique De Louvain, Brussels, Belgium.

Advanced Healthcare Materials
|June 23, 2026
PubMed
Summary
This summary is machine-generated.

Bioengineered ovarian platforms offer new hope for premature ovarian insufficiency (POI). Cell-based hormone replacement therapies (cHRTs) aim to restore endocrine function and fertility by mimicking natural hormone regulation.

Keywords:
bioengineered ovarian constructshormone replacement therapyovarypremature ovary insufficiency

More Related Videos

Co-transplantation of Human Ovarian Tissue with Engineered Endothelial Cells: A Cell-based Strategy Combining Accelerated Perfusion with Direct Paracrine Delivery
07:40

Co-transplantation of Human Ovarian Tissue with Engineered Endothelial Cells: A Cell-based Strategy Combining Accelerated Perfusion with Direct Paracrine Delivery

Published on: May 16, 2018

Related Experiment Videos

Last Updated: Jun 24, 2026

Collection of Human Follicular Fluid, Follicle Somatic Cells, and Immature Oocytes from Individuals Undergoing In Vitro Fertilization
06:40

Collection of Human Follicular Fluid, Follicle Somatic Cells, and Immature Oocytes from Individuals Undergoing In Vitro Fertilization

Published on: October 24, 2025

Co-transplantation of Human Ovarian Tissue with Engineered Endothelial Cells: A Cell-based Strategy Combining Accelerated Perfusion with Direct Paracrine Delivery
07:40

Co-transplantation of Human Ovarian Tissue with Engineered Endothelial Cells: A Cell-based Strategy Combining Accelerated Perfusion with Direct Paracrine Delivery

Published on: May 16, 2018

Area of Science:

  • Reproductive Endocrinology
  • Bioengineering
  • Tissue Engineering

Background:

  • Premature ovarian insufficiency (POI) is an endocrine disorder causing infertility and hypoestrogenism before age 40.
  • Current hormone replacement therapies (HRTs) inadequately replicate natural ovarian feedback loops.
  • Bioengineering offers novel solutions for restoring ovarian endocrine function.

Purpose of the Study:

  • To review advancements in bioengineered platforms for mimicking ovarian endocrine function.
  • To highlight progress in cell-based hormone replacement therapies (cHRTs) for POI.
  • To discuss challenges and potential of cHRTs in restoring reproductive and systemic health.

Main Methods:

  • Review of 3D follicle-mimetic constructs, scaffold-free organoids, and ovary-on-a-chip systems.
  • Emphasis on steroidogenesis reconstitution and granulosa-theca co-cultures.
  • Analysis of cell-based therapies designed to re-engage the hypothalamic-pituitary-ovarian (HPO) axis.

Main Results:

  • Development of sophisticated bioengineered platforms mimicking ovarian endocrine function.
  • Progress in creating co-culture systems and dynamic microphysiological systems.
  • Identification of key advancements in steroidogenesis and HPO axis re-engagement.

Conclusions:

  • Cell-based hormone replacement therapies (cHRTs) represent a paradigm shift for POI treatment.
  • cHRTs hold potential for restoring endocrine health, fertility, and systemic homeostasis.
  • Overcoming challenges in immunoisolation and vascularization is crucial for clinical translation.